Neogene Therapeutics
Latest round
- Series A
Last raised
- Sep 2020
Total raised
- $110M
Investors
- 8
About Neogene Therapeutics
Neogene Therapeutics, Inc.Founded in 2018 and headquartered in Amsterdam, Netherlands, Neogene Therapeutics, Inc. focuses on creating curative cell therapies for oncology. The company was established by Carsten Linnemann, who has a background in immunotherapy.Neogene Therapeutics, Inc. is dedicated to the development of innovative cell therapies designed specifically for cancer treatment.Neogene Therapeutics, Inc. generates revenue primarily through partnerships, collaborations, and the sale of its therapeutic products.The acquisition by AstraZeneca is set to accelerate the development of potentially curative cell therapies. Neogene Therapeutics plans to further enhance its product pipeline and expand into new markets, with significant focus on global regions that are currently underserved in oncology.00 mn, inclusive of potential contingent considerations, will support these initiatives and foster innovation in cancer treatment.
Who invested in Neogene Therapeutics
8 investors across 1 round
See all investors in Neogene Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 14, 2020
Amount
$110M
Investors
Questions about Neogene Therapeutics
Who invested in Neogene Therapeutics?
Neogene Therapeutics has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neogene Therapeutics raised?
Neogene Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Neogene Therapeutics last raise money?
Neogene Therapeutics's most recent round on record is a Series A, in Sep 2020.
What does Neogene Therapeutics do?
Neogene Therapeutics is a biotechnology company.
Where is Neogene Therapeutics headquartered?
Neogene Therapeutics is headquartered in Amsterdam, Netherlands.
Which VCs invest in companies like Neogene Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Neogene Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Neogene Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.